Effects of imidazoline I2 receptor ligands on acute nociception in rats

Neuroreport. 2012 Jan 25;23(2):73-7. doi: 10.1097/WNR.0b013e32834e7db3.

Abstract

This study examined the antinociceptive effects of seven imidazoline I2 receptor ligands in a rat warm water tail withdrawal procedure (46 and 50 °C). Agmatine, 2-BFI, phenyzoline, and diphenyzoline produced a significant antinociceptive activity at 46 °C. BU224, S22687, and idazoxan had no effect at 46 °C up to doses that altered the locomotor activity. None of the drugs showed antinociceptive activity at 50 °C. It is suggested that I2 receptor agonists have antinociceptive activity for acute phasic pain under weak noxious stimulus, and the effects are efficacy-dependent. These data explain the findings that I2 receptor agonists enhance the antinociceptive effects of opioids and support developing higher-efficacy I2 receptor agonists for the treatment of pain.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesics / pharmacology*
  • Analgesics, Opioid / pharmacology
  • Animals
  • Imidazoline Receptors / agonists*
  • Ligands
  • Male
  • Pain / drug therapy*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Analgesics
  • Analgesics, Opioid
  • Imidazoline Receptors
  • Ligands
  • imidazoline receptor 2